ASPEN PHARMACARE HOLDINGS LIMITED - Resignation of Ms Babalwa Ngonyama
Resignation of Ms Babalwa Ngonyama
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)
RESIGNATION OF MS BABALWA NGONYAMA
The Aspen Holdings Board of Directors (“the Board”) has accepted the resignation of Ms Babalwa
Ngonyama as a director of the Board. Ms Ngonyama has diligently served as an independent non-
executive director of Aspen Holdings since 1 April 2016 and chaired the Audit & Risk Committee since 1
January 2018.
Ms Ngonyama’s resignation takes effect immediately.
The Board wishes to express its sincere appreciation to Ms Ngonyama for her service to Aspen over the
past seven years.
The Board is in the process of reviewing potential candidates for appointment to the Board and will make
further announcements regarding the appointment of an interim chair of the Audit & Risk Committee.
Durban
29 May 2023
Sponsor
Investec Bank Limited
Date: 29-05-2023 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
